{"id":"W3109355046","doi":"10.1080/09546634.2020.1839008","title":"Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; LEO Pharma; Sanofi Genzyme; Incyte; Medac; XBiotech; Kiniksa Pharmaceuticals; Fresenius Medical Care North America; Dermira; UCB Pharma; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Biogen; Celgene; Samsung; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Corticosteroid; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002254612,0.0003485917,0.002686088,0.0001706213,0.00006345812,0.00005183077,0.00009089703,0.0001302827,0.00007353217],"category_scores_gemma":[0.001576846,0.0001867702,0.000297244,0.0001635619,0.0000921848,0.0001351968,0.000039739,0.0001829667,0.000006386853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001026094,"about_ca_system_score_gemma":0.0001251752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001987604,"about_ca_topic_score_gemma":0.000003254322,"domain_scores_codex":[0.9961609,0.001066311,0.001789653,0.0003202359,0.0003672739,0.0002955753],"domain_scores_gemma":[0.9967325,0.001619499,0.0006126948,0.0001874809,0.0001527129,0.0006951197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4866738,0.001624962,0.4833016,0.00001534679,0.001440366,0.00311953,0.001507062,0.00003964426,0.00008785738,0.000009587507,0.0001692298,0.02201102],"study_design_scores_gemma":[0.521992,0.003786356,0.4713046,0.00013644,0.0007031434,0.0002917836,0.0001185233,0.0002347375,0.0008488616,0.0001554409,0.0002060249,0.0002220897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829371,0.000447551,0.0005643428,0.01397519,0.00008075071,0.00191166,0.00003751785,0.00002675048,0.00001913618],"genre_scores_gemma":[0.9906923,0.00005851997,0.001195067,0.007896775,0.00002838524,0.00008439454,0.00002069807,0.00001641748,0.000007463632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03531823,"threshold_uncertainty_score":0.7616265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03295868150867071,"score_gpt":0.3156504988386487,"score_spread":0.282691817329978,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}